Literature DB >> 23743522

Quality of reporting of randomized controlled trials published in Intensive Care Medicine from 2001 to 2010.

Nicola Latronico1, Marta Metelli, Maddalena Turin, Simone Piva, Frank A Rasulo, Cosetta Minelli.   

Abstract

PURPOSE: To evaluate the methodological quality of randomized controlled trials (RCTs) published in Intensive Care Medicine from 2001 to 2010, and to compare it with a previous review of RCTs published from 1975 to 2000.
METHODS: We assessed the quality of reporting of randomization, blinding and participant flow, both individually and combined within the Jadad scale, and compared them with findings from our previous review. For RCTs published from 2001 to 2010, we also evaluated the frequency of distorted finding presentation (spin) and inflated predicted treatment effect (delta inflation).
RESULTS: In the 221 RCTs from 2001 to 2010, the sample size was significantly larger than in the older series, and there was a higher proportion of studies with negative findings. Reporting of the rationale for sample size estimation and allocation concealment increased significantly, but reporting of other important individual methodological components did not change substantially compared with the previous period and remained low. Among RCTs from 2001 to 2010, a spin strategy was used in 69 of 111 RCTs with statistically negative results, while delta inflation was present in 7 of 11 RCTs evaluating survival as a primary outcome. Papers with higher Jadad scores were cited more often than the others.
CONCLUSIONS: Quality of reporting of RCTs published in Intensive Care Medicine has only partly improved over time, and spin and delta bias are of frequent occurrence. There is a need for stronger adherence to CONSORT recommendations, with special emphasis on accurate description of randomization and blindness, and correct reporting of statistically non-significant results.

Entities:  

Mesh:

Year:  2013        PMID: 23743522     DOI: 10.1007/s00134-013-2947-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  54 in total

1.  Multiplicity in randomised trials II: subgroup and interim analyses.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

2.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

3.  Methodological reporting of randomized clinical trials in major gastroenterology and hepatology journals in 2006.

Authors:  Yu Bai; Jun Gao; Duo-Wu Zou; Zhao-Shen Li
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

4.  Assessing the quality of randomized controlled trials from two leading cancer journals using the CONSORT statement.

Authors:  Necdet Süt; Mustafa Senocak; Omer Uysal; Hilal Köksalan
Journal:  Hematol Oncol Stem Cell Ther       Date:  2008 Jan-Mar

Review 5.  Methodological quality of randomised controlled trials in burns care. A systematic review.

Authors:  Stefan Danilla; Jason Wasiak; Susana Searle; Cristian Arriagada; Cesar Pedreros; Heather Cleland; Anneliese Spinks
Journal:  Burns       Date:  2009-07-09       Impact factor: 2.744

6.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

7.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

8.  Factors related to the frequency of citation of epidemiologic publications.

Authors:  Kristian B Filion; I Barry Pless
Journal:  Epidemiol Perspect Innov       Date:  2008-02-26

Review 9.  Reporting of sample size calculation in randomised controlled trials: review.

Authors:  Pierre Charles; Bruno Giraudeau; Agnes Dechartres; Gabriel Baron; Philippe Ravaud
Journal:  BMJ       Date:  2009-05-12

10.  Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies.

Authors:  Andreas Lundh; Peter C Gøtzsche
Journal:  BMC Med Res Methodol       Date:  2008-04-21       Impact factor: 4.615

View more
  15 in total

1.  Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.

Authors:  Elie Azoulay; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-01-24       Impact factor: 17.440

2.  Outcomes and statistical power in adult critical care randomized trials.

Authors:  Michael O Harhay; Jason Wagner; Sarah J Ratcliffe; Rachel S Bronheim; Anand Gopal; Sydney Green; Elizabeth Cooney; Mark E Mikkelsen; Meeta Prasad Kerlin; Dylan S Small; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

3.  Measuring and Analyzing Length of Stay in Critical Care Trials.

Authors:  Michael O Harhay; Sarah J Ratcliffe; Dylan S Small; Leah H Suttner; Michael J Crowther; Scott D Halpern
Journal:  Med Care       Date:  2019-09       Impact factor: 2.983

4.  Old wine in new bottles: should we publish old data?

Authors:  Matthieu Resche-Rigon; Daniel Talmor; John P Kress
Journal:  Intensive Care Med       Date:  2013-11-26       Impact factor: 17.440

5.  CONSORT item reporting quality in the top ten ranked journals of critical care medicine in 2011: a retrospective analysis.

Authors:  Ana Stevanovic; Sabine Schmitz; Rolf Rossaint; Tobias Schürholz; Mark Coburn
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

6.  Interpretation of Results of Studies Evaluating an Intervention Highlighted in Google Health News: A Cross-Sectional Study of News.

Authors:  Romana Haneef; Clement Lazarus; Philippe Ravaud; Amélie Yavchitz; Isabelle Boutron
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

7.  Findings from a novel approach to publication guideline revision: user road testing of a draft version of SQUIRE 2.0.

Authors:  Louise Davies; Kyla Z Donnelly; Daisy J Goodman; Greg Ogrinc
Journal:  BMJ Qual Saf       Date:  2015-08-11       Impact factor: 7.035

8.  Outcome Reporting Bias in Government-Sponsored Policy Evaluations: A Qualitative Content Analysis of 13 Studies.

Authors:  Arnaud Vaganay
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

9.  Interpretation of health news items reported with or without spin: protocol for a prospective meta-analysis of 16 randomised controlled trials.

Authors:  Romana Haneef; Amélie Yavchitz; Philippe Ravaud; Gabriel Baron; Ivan Oransky; Gary Schwitzer; Isabelle Boutron
Journal:  BMJ Open       Date:  2017-11-17       Impact factor: 2.692

10.  Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin.

Authors:  Dongguang Wang; Lingmin Chen; Lian Wang; Fang Hua; Juan Li; Yuxi Li; Yonggang Zhang; Hong Fan; Weimin Li; Mike Clarke
Journal:  J Clin Epidemiol       Date:  2021-07-02       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.